HealthStream
HSTM
159 hedge funds and large institutions have $553M invested in HealthStream in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 17 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 44
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
2% more funds holding
Funds holding: 156 → 159 (+3)
1.15% less ownership
Funds ownership: 72.27% → 71.11% (-1.2%)
9% less capital invested
Capital invested by funds: $611M → $553M (-$57.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $200K
Top Buyers
Top Sellers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$12.2M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$8.59M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$5.53M |
| 4 |
Morgan Stanley
New York
|
-$2.42M |
| 5 |
EP
Eversept Partners
New York
|
-$2.22M |
HSTM Hedge Fund Activity: Q4 2021 in Review
159 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in HealthStream (HSTM) for Q4 2021, worth a combined $553M — down 9.5% from $611M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new HSTM positions and 17 closed out — a net gain of 4 holders — while 61 added to existing stakes and 44 trimmed.
The largest buyer was Ameriprise, adding an estimated $5.33M. The largest seller was Bank of Montreal, exiting entirely with an estimated $12.2M sold.
- 159 institutional investors held HealthStream (HSTM) as of Q4 2021, up from 156 in Q3 2021.
- Funds reported $553M of HealthStream stock for Q4 2021, down 9.5% quarter-over-quarter.
- 21 funds opened new HealthStream positions in Q4 2021 and 17 closed out, a net change of +4 holders.
- The largest HealthStream buyer in Q4 2021 was Ameriprise, an estimated $5.33M added.
- The largest HealthStream seller in Q4 2021 was Bank of Montreal, an estimated $12.2M sold.
Based on aggregated 13F filings for Q4 2021.